Dutch imaging experts believe this new approach—letting artificial intelligence read cases only in which it is certain—could eventually serve as a solution to workforce shortages. 

Cardiology is number one in FDA Breakthrough Device designations at 218, the highest number out of all other clinical categories. This includes 16 new devices cleared in the past year.

A new generation of AI-native researchers is leading the way in the war on cancer. This next crop of scientists is AI-native, interdisciplinary—and comfortable challenging assumptions. 

The roots of medicine are in the promotion of human welfare, aka humanitarianism. Healthcare AI can either degrade or reinforce this heritage. Who picks the path? 

Epic confirmed on Tuesday that its long-rumored AI scribe feature is a reality. The company said it’s working with Microsoft-owned Nuance—and with clinical documentation standout Abridge—to add the feature to its platform.

The company operates across six countries with plans to enter the U.S., offering its flagship BMVision Kidney, helping to detect malignant lesions in the organ. 

New research published in Lancet Digital Health details the improved cancer detection rates achieved when AI serves as a second reader. 

If not for off-limits data, AI might have a decent shot at curing cancer.